{
  "id": "b2f392de331c9e85",
  "title": "Pediatric studies and labeling additions required by the U . S . FDA for novel drugs approved from 2011 to 2023 : A retrospective cohort study",
  "description": "20251217T220000Z",
  "content": "",
  "source": "journals.plos.org",
  "source_url": "https://journals.plos.org:443/plosmedicine/article?id=10.1371/journal.pmed.1004651",
  "published_at": "20251217T220000Z",
  "fetched_at": "2025-12-18T00:22:47.263985+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://journals.plos.org:443/plosmedicine/article?id=10.1371/journal.pmed.1004651",
    "url_mobile": "",
    "title": "Pediatric studies and labeling additions required by the U . S . FDA for novel drugs approved from 2011 to 2023 : A retrospective cohort study",
    "seendate": "20251217T220000Z",
    "socialimage": "https://journals.plos.org/plosmedicine/article/figure/image?id=10.1371/journal.pmed.1004651.g002&size=inline",
    "domain": "journals.plos.org",
    "language": "English",
    "sourcecountry": "United States"
  }
}